Abaxis, Inc.
https://www.abaxis.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Abaxis, Inc.
Orthopedic Device Firms Lobby Hard On COVID-19 Relief And Reimbursements, Among Other Issues
Firms including Depuy Synthes, Medtronic Inc., and Zimmer Biomet Holdings Inc., spent thousands of dollars lobbying Congress last winter.
Medtech Business Models: All Razor And No Blades – Is “Big Iron” Back In Vogue?
The conventional wisdom in the medtech industry is to pursue the “razor-razor blade” business model, as each placement of capital equipment generates a lucrative annuity of recurring revenues from disposables. The corollary to this conventional wisdom is that so-called “big iron” is to be avoided as, in sharp contrast, it suffers from greater early cash requirements and longer sales cycles that create difficulties forecasting quarterly revenues, and provides no annuities. But that view is no longer the only one that counts, Health Advances CEO Mark Speers argues.
Deals Shaping the Medical Industry, January 2018
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in December 2017.
CLIA Waiver Wave? Applications Up In FY 2014 After A Prior-Year Lull
The volume of applications for diagnostic test waivers under the Clinical Laboratory Improvement Amendments increased fivefold in FY 2014, but the total numbers are small, and the change may simply reflect routine year-to-year variation.
Company Information
- Industry
-
Medical Devices
- Diagnostic Equipment & Supplies
-
In Vitro Diagnostics
- Hematology, Coagulation
- Other Names / Subsidiaries
-
- Abaxis Global Diagnostics